40
Participants
Start Date
May 19, 2016
Primary Completion Date
October 26, 2017
Study Completion Date
October 26, 2017
ATM-AVI
"Cohort 1:~(Creatinine clearance \> 50 mL/min)6500mg ATM/1777mg AVI on day 1 followed by total daily dose of 6000mg ATM/1640mg AVI~Cohorts 2 and 3:~(Creatinine clearance \> 50 mL/min) As above, or: 6500 mg ATM/2167 mg on Day 1 followed by a total daily dose of 6000 mg ATM/2000 m AVI~(Creatinine clearance 31 - 50 mL/min) 4250 mg ATM/1162 mg AVI on Day 1 followed by total daily dose 3000 mg ATM/820 mg AVI, or:~4250 mg ATM/1417 mg AVI on Day 1 followed by total daily dose 3000 mg ATM/1000 mg AVI"
Metronidazole
Metronidazole 500mg infused over 1 hour every 8 hours
Hospital Universitario Reina Sofia, Córdoba
Universitaetsklinikum Schleswig-Holstein, Klinik fuer Infektiologie und Mikrobiologie, DZIF-CTU, Lübeck
Hospital Universitario Virgen Macarena, Seville
Hospital Universitario Virgen del Rocio, Seville
Hospital Universitario Cruces, Barakaldo
Universitaetsklinikum Koeln Innere Medizin I, Cologne
University Hospital C., Lille
CHU Limoges, Limoges
Hospital Universitario Son Espases, Palma de Mallorca
Hospital Universitari del Mar, Barcelona
Hospital Universitario Mutua de Tarrasa, Terrassa
Lead Sponsor
Innovative Medicines Initiative
OTHER
Pfizer
INDUSTRY